YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Program for Caregivers Involved With Mental Health Services

Early Phase 1

Completed

Conditions: Mental Illness

Interventions: Behavioral: Mentalization based therapy

First Posted Date: 2013-06-07

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 18

Registration Number: NCT01872585

Locations: 🇺🇸
West Haven Mental Health Clinic, West Haven, Connecticut, United States

Attention Training for Opioid-maintained Cocaine Users

Phase 4

Completed

Conditions: Cocaine
Addiction
Methadone
Opiates

Interventions: Behavioral: Attentional retraining
Behavioral: Control condition

First Posted Date: 2013-06-06

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 8

Registration Number: NCT01870882

Locations: 🇺🇸
Department of Veterans Affairs Hospital, West Haven, Connecticut, United States

Feasibility and Impact of a Decision Rule for Imaging of Emergency Department Patients With Suspected Kidney Stone

Not Applicable

Completed

Conditions: Kidney Stones

Interventions: Radiation: Ultra low dose CT scan
Radiation: No imaging
Radiation: Regular CT or Low Dose CT scan

First Posted Date: 2013-06-05

Last Posted Date: 2020-03-20

Lead Sponsor: Yale University

Target Recruit Count: 264

Registration Number: NCT01869647

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Naltrexone for Antipsychotic-Induced Weight Gain

Not Applicable

Completed

Conditions: Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorder
Bipolar Disorder
Severe Major Depression With Psychotic Features

Interventions: Drug: Placebo
Drug: Naltrexone

First Posted Date: 2013-05-31

Last Posted Date: 2021-10-01

Lead Sponsor: Yale University

Target Recruit Count: 144

Registration Number: NCT01866098

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia

Phase 2

Completed

Conditions: Opiate Dependence
Stimulant Dependence

Interventions: Drug: Atomoxetine

First Posted Date: 2013-05-27

Last Posted Date: 2017-04-27

Lead Sponsor: Yale University

Target Recruit Count: 90

Registration Number: NCT01863251

Locations: 🇲🇾
Universiti Sains Malaysia, Kota Bharu, Malaysia

Linking Former Inmates to Primary Care

Completed

Conditions: Substance Abuse
Asthma
Hypertension
Depression

Interventions: Other: Primary care redesign

First Posted Date: 2013-05-27

Last Posted Date: 2017-10-25

Lead Sponsor: Yale University

Target Recruit Count: 816

Registration Number: NCT01863290

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
Contra Costa Health Services (East and West Contra Costa), Martinez, California, United States
🇺🇸
Southeast Health Center, San Francisco, California, United States

and more 8 locations

Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer

Phase 2

Completed

Conditions: Her2-Positive Breast Cancer

Interventions: Drug: Pertuzumab
Drug: Trastuzumab
Drug: Paclitaxel
Drug: 5-fluorouracil
Drug: Epirubicin
Drug: Cyclophosphamide

First Posted Date: 2013-05-17

Last Posted Date: 2020-03-31

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT01855828

Locations: 🇺🇸
Yale University Smilow Cancer Hospital, New Haven, Connecticut, United States

Breast Cancer Molecular Analysis Protocol

Completed

Conditions: Metastatic Breast Cancer

Interventions: Procedure: Core Biopsy

First Posted Date: 2013-05-16

Last Posted Date: 2016-11-17

Lead Sponsor: Yale University

Target Recruit Count: 121

Registration Number: NCT01855503

Locations: 🇺🇸
Smilow Hospital Breast Center, New Haven, Connecticut, United States

Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes

Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Exenatide

First Posted Date: 2013-05-16

Last Posted Date: 2016-07-07

Lead Sponsor: Yale University

Target Recruit Count: 17

Registration Number: NCT01855490

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Cannabinoids and Cerebellar-Motor Functioning

Early Phase 1

Completed

Conditions: Psychotic Disorders
Cannabis

Interventions: Drug: Placebo
Drug: THC

First Posted Date: 2013-05-14

Last Posted Date: 2022-02-11

Lead Sponsor: Yale University

Target Recruit Count: 57

Registration Number: NCT01853020

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy